U. Dernedde

1.2k total citations
5 papers, 18 citations indexed

About

U. Dernedde is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Otorhinolaryngology. According to data from OpenAlex, U. Dernedde has authored 5 papers receiving a total of 18 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 1 paper in Otorhinolaryngology. Recurrent topics in U. Dernedde's work include Lung Cancer Treatments and Mutations (3 papers), Lung Cancer Diagnosis and Treatment (2 papers) and HER2/EGFR in Cancer Research (1 paper). U. Dernedde is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), Lung Cancer Diagnosis and Treatment (2 papers) and HER2/EGFR in Cancer Research (1 paper). U. Dernedde collaborates with scholars based in United Kingdom and United States. U. Dernedde's co-authors include Lee Shepstone, Allan Clark, A. John Barrett, M. Caroline Burton, Jalpa Kotecha, Andrew M. Wilson, T. Geldart, Lauren Jones, Petra Jankowska and Tanya Ahmad and has published in prestigious journals such as Journal of Clinical Oncology, Thorax and Journal of Thoracic Oncology.

In The Last Decade

U. Dernedde

5 papers receiving 18 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
U. Dernedde United Kingdom	3	12	9	3	3	2	5	18
Timur Andabekov United Kingdom	3	11 0.9×	9 1.0×		5 1.7×	2 1.0×	4	15
Aditi Aggarwal India	4	16 1.3×	15 1.7×		2 0.7×	2 1.0×	12	26
Constanța Mihăescu-Pinţia Romania	3	15 1.3×	5 0.6×		3 1.0×	2 1.0×	6	27
Artem Poltoratsky Australia	2	8 0.7×	7 0.8×		2 0.7×	2 1.0×	2	10
Y H Galán Alvarez Cuba	2	17 1.4×	7 0.8×		2 0.7×	4 2.0×	3	24
L. Paz-Ares Spain	2	13 1.1×	13 1.4×		3 1.0×	3 1.5×	3	17
Matthew I. Miller United States	3	8 0.7×	7 0.8×		2 0.7×	2 1.0×	4	16
Eli Van Allen United States	2	9 0.8×	8 0.9×		2 0.7×		3	11
Andrew Wight United Kingdom	2	15 1.3×	13 1.4×		6 2.0×	3 1.5×	4	22
Emma Martin United Kingdom	2	8 0.7×	17 1.9×		4 1.3×	1 0.5×	3	42

Countries citing papers authored by U. Dernedde

Since Specialization

Citations

This map shows the geographic impact of U. Dernedde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Dernedde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Dernedde more than expected).

Fields of papers citing papers by U. Dernedde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U. Dernedde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Dernedde. The network helps show where U. Dernedde may publish in the future.

Co-authorship network of co-authors of U. Dernedde

This figure shows the co-authorship network connecting the top 25 collaborators of U. Dernedde. A scholar is included among the top collaborators of U. Dernedde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U. Dernedde. U. Dernedde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Kotecha, Jalpa, et al.. (2020). Evaluating the delay prior to primary care presentation in patients with lung cancer: a cohort study. BJGP Open. 5(2). BJGPO.2020.0130–BJGPO.2020.0130. 7 indexed citations

2.

Popat, Sanjay, Laura Hughes, Mary O’Brien, et al.. (2017). P3.02b-046 Afatinib Benefits Patients with Confirmed/Suspected EGFR Mutant NSCLC, Unsuitable for Chemotherapy (TIMELY Phase II Trial). Journal of Thoracic Oncology. 12(1). S1215–S1216. 3 indexed citations

3.

Clark, Allan, U. Dernedde, M. Caroline Burton, et al.. (2016). P80 Symptoms, delay to presentation and survival in lung cancer. Thorax. 71(Suppl 3). A127.2–A128. 2 indexed citations

4.

Dernedde, U., Catherine Oakley, James Larkin, et al.. (2008). South West London Cancer Network (SWLCN) audit of patients with chemotherapy-induced febrile neutropenia (CIFN). Journal of Clinical Oncology. 26(15_suppl). 20653–20653. 1 indexed citations

5.

Dernedde, U., et al.. (2006). Three-year Single Institution Audit on Transfusion Requirements in Oncology Patients. Clinical Oncology. 19(4). 223–227. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact